This paper is a prospective study of patients with advanced human immunodeficiency virus infection and chronic diarrhoea for which no cause could be found after extensive investigations, including examination of multiple stool specimens for all known faecal pathogens and the histological examination of small and large bowel biopsy specimens. Of 39 such patients recruited from 155 prospectively investigated patients, eight had a possible cause of diarrhoea identified on follow up investigations, including small bowel neoplasms in three and cytomegalovirus in two. In 17 of the remaining 31 the diarrhoea resolved completely in a mean of seven months from its onset. Eleven had continuing mild or intermittent diarrhoea and three had more than 1 litre of diarrhoea daily for which no cause could be found. The median survival for patients with 'pathogen negative' diarrhoea was 48.7 months, which is similar to that of control patients with no diarrhoea and significantly longer than that of matched patients with a gastrointestinal pathogen (9.6 months). (Gut 1995; 36: 283-286) 
Previous studies of diarrhoea in human immunodeficiency virus (HIV) seropositive patients have identified a number of patients in whom no cause for the diarrhoea could be found.l The simplest explanation for this is that the investigations carried out fail to identify a proportion of the pathogens present. Alternatively the diarrhoea may be caused by a novel pathogen or by a gut autonomic neuropathy,5 6 bacterial overgrowth6 7 or flat mucosa induced by HIV infection of the gut mucosa.8 If this last mechanism was important, the diarrhoea would not be expected to resolve and might well become worse as HIV infection progressed. Little is known, however, about the outcome and prognosis of diarrhoea in these patients.
We recruited a cohort of patients with apparently 'pathogen negative' diarrhoea and performed further investigations to identify possible pathogens that had been missed initially. We then followed them up prospectively to assess the outcome of the diarrhoea, and compared their survival to two groups of contemporaneously recruited controls: patients with a known pathogen and subjects without diarrhoea.
Methods

PATIENTS
Patients all of whom had a CD4 lymphocyte count of less than 200 cells/mm3 were drawn from a cohort of 155 patients who had been recruited as part of a prospective study of diarrhoea (defined as three or more liquid motions per day for at least one month). No cause for diarrhoea had been identified after a series of investigations.
Microbiology
Six stool specimens were cultured for faecal pathogens on salmonella/shigella agar medium, campylobacter selective medium and selanite F enrichment medium and Lowenstein-Jensen slopes for mycobacteria. Concentrated wet preparations from each specimen were examined by direct microscopy for ova, cysts, and parasites. Smears were stained with auramine-phenol for cryptosporidia with confirmation by a modified acid fast method. A cause of diarrhoea was defined if on at least one occasion a recognised opportunistic or non-opportunist pathogen was seen. We included within this definition a number of organisms whose pathogenicity is uncertain (see Table I ). Small (16) , faecal incontinence (13) , and urgency (16) . Some patients had nausea (12) , nocturnal diarrhoea (6), excessive mucus (4) or blood in the stool (2), and mild tenderness on abdominal palpation (4). The mean stool frequency was six per day and mean stool volume 593 ml. Twenty one patients were taking zidovudine and the two taking dideoxyinosine (ddI) had both stopped the drug for three weeks before presenting for investigation. Twenty one patients had been abroad in the three months before the onset of diarrhoea but in only two cases had the (Table II) .
CMV infection was found in three of these patients and the diarrhoea improved with ganciclovir treatment in two. One had inclusions in both colonic and small bowel biopsy specimens obtained three months after the initial biopsies and another had marked CMW gastritis. A third patient had a few CMV inclusions in caecal biopsy specimens and adenovirus infection of the left colon. His diarrhoea did not resolve after treatment with foscarnet.
Three patients were found to have malignant infiltration of the small bowel. In one patient with widespread cutaneous Kaposi's sarcoma the barium meal and follow through showed numerous fitting defects suggestive of Kaposi's sarcoma involving a substantial area of the small bowel and this was confirmed histologically. Two patients had small bowel lymphoma, diagnosed in one case at laparotomy after recurrent bouts of abdominal pain and pyrexia, and in a second at necropsy.
One patient was found to have microsporidiosis on his second set of duodenal biopsy specimens and in stool specimens.
The final patient in whom a pathogen was uncovered had diarrhoea that settled but he developed abdominal pain and cholangiographic evidence of AIDS related sclerosing cholangitis. Cryptosporidia were identified in bile, ampullary, and bile duct biopsy specimens.
Patients were reviewed for up to 30 months after initial investigations. In 17 of 31 with no cause for the diarrhoea, this resolved completely without subsequent recurrence in a mean of seven months (range 2-37 months). A further seven patients had mild daily diarrhoea, four had intermittent diarrhoea, and only three had severe diarrhoea. In these three patients, stool volumes were consistently more than a litre a day with little response to opiates. The diarrhoea persisted but decreased in volume (to less than 500 mi/day) with fasting. All three continued to lose weight at a rate of 0 5 to 1 kg per month despite oral protein and energy supplements. They had five hour urinary xylose excretions of less than 10% and a B 12 absorption of less than 8%. All had therapeutic trials of metronidazole, ciprofloxacin, and foscamet or ganciclovir without any improvement in their symptoms, and there was no change when all treatment was stopped for three weeks. All three have had small bowel enteroscopy performed using a paediatric colonoscope, and serial biopsy specimens showed no evidence of infection or neoplasia. Small bowel aspirates grew less than 104 CFU/ml of bacteria.
There was no difference in CD4 count, weight, stool frequency or volume or associated symptoms between those patients whose diarrhoea settled and those who had ongoing symptoms (Table II) .
The survival for patients in whom no cause was found for the diarrhoea was similar to that of patients without diarrhoea (median 48 months) and significantly longer than that of patients with an opportunistic pathogen causing diarrhoea (9.6 months) (Figure) . Discussion This is the first longitudinal prospective study of a group of HIV seropositive patients with diarrhoea in which no pathogen has been uncovered despite extensive investigations. We have found that in most patients the diarrhoea resolved spontaneously and only in 20% did a probable cause become apparent on subsequent investigation, most commonly, CMV infection or malignant infiltration of the small bowel.
The importance of CMV inclusions in a macroscopically normal colonic mucosa and in the upper gut of patients with diarrhoea is unclear but in two of three patients in whom this occurred, the diarrhoea improved with anti-CMV treatment and in a third patient, adenovirus was also found, which might have been responsible for the symptoms. The findings of only one case in which CMV inclusions were seen solely in caecal biopsy specimens, reinforces our previous view that colonoscopy has little advantage over sigmoidoscopy with biopsy in the diagnosis of AIDS related diarrhoea. '2 Although malignant infiltration of the gut with Kaposi's sarcoma or lymphoma is common, this rarely causes diarrhoea. '3 14 Small bowel enteroscopy, however, should be considered in patients with persistently negative diarrhoea to detect the occasional case.
The cause of the diarrhoea in the remaining 31 patients is unclear. There has been one previous report of diarrhoea and bacteraemia in an AIDS patient caused by enteroinvasive Echerichia colil5 and one of chronic diarrhoea and malabsorption thought to be caused by enteroadherent E coli found attached to ileal and colonic enterocytes, which responded to ciprofloxacin.16 Although pathogenic subtypes of E coli would not have been identified by our investigations, we do not believe this was the cause of diarrhoea as all those with persistent symptoms were treated with ciprofloxacin without benefit.
We do not routinely perform quantitative cultures of duodenal aspirate in our patients. Two small studies in HIV have found bacterial overgrowth, mainly of mouth flora, associated with gastric hypoacidity in HIV seropositive patients.6 7 In both these studies, overgrowth was not necessarily associated with diarrhoea and the numbers of organisms found was less than that seen in conditions such as tropical sprue and blind loop syndrome. The high rate of resolution of the diarrhoea in our patients without antibacterial drugs is against bacterial overgrowth being the cause of diarrhoea and the three patients with the most severe persisting diarrhoea had cultures of duodenal fluid that did not show infection.
Spontaneous resolution or easy symptomatic control of pathogen negative diarrhoea in HIV positive patients has been noted previously.'7 18 Self limited chronic idiopathic diarrhoea has also been noted in immunocompetent subjects19 and has many similarities with that in our patients: blood and mucus in the stools, nausea, vomiting, and abdominal cramps were rare but urgency and incontinence occurred in about 30%; most also had a history of recent travel abroad but family and household contacts were not affected.
The case control study shows that the patients with pathogen negative diarrhoea survive considerably longer than patients with a recognised gut pathogen, implying that they do not have an occult infection comparable with cryptosporidium, microsporidium or CMV. The presence of pathogen negative diarrhoea does not seem to adversely affect their prognosis compared with that of similar patients without diarrhoea. Patients may be reassured that providing known pathogens are rigorously excluded the diarrhoea will probably resolve or improve: only three patients, representing less than 2% of the original cohort, had severe daily diarrhoea that eluded diagnosis.
